Author:
Farinati Fabio,Cardin Romilda,Piciocchi Marika,Rodríguez-Castro Kryssia,Maddalo Gemma,Rugge Massimo
Publisher
Springer Berlin Heidelberg
Reference131 articles.
1. Allavena P, Mantovani A (2012) Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol 167:195–205
2. Alvi A, Ansari SA, Ehtesham NZ et al (2011) Concurrent proinflammatory and apoptotic activity of a Helicobacter pylori protein (HP986) points to its role in chronic persistence. PLoS One 6:e22530
3. Annibale B, Aprile MR, D’ambra G, Caruana P, Bordi C, G. DF (2000) Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14:625–634
4. Anonymous (1993) An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 341:1359–1362
5. Anonymous (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1–241